| |
| |
|
| Insider
Information: |
Alton Gregg H |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
61,846 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,731,983 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,846 |
|
|
| Total
Value |
$3,731,983 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-02-02 |
4 |
AS |
$105.20 |
$1,268,719 |
D/D |
(12,000) |
111,694 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-02-13 |
4 |
A |
$85.61 |
$21,232 |
D/D |
248 |
111,942 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
104,274 |
216,216 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-02-17 |
4 |
D |
$103.84 |
$6,935,889 |
D/D |
(66,794) |
149,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-03-02 |
4 |
AS |
$103.36 |
$1,243,615 |
D/D |
(12,000) |
147,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-03-02 |
4 |
OE |
$19.09 |
$190,850 |
D/D |
10,000 |
159,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-04-01 |
4 |
AS |
$96.29 |
$675,715 |
D/D |
(7,000) |
145,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-04-01 |
4 |
OE |
$19.09 |
$95,425 |
D/D |
5,000 |
152,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-04-08 |
4 |
OE |
$19.09 |
$95,425 |
D/D |
5,000 |
150,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-04-08 |
4 |
AS |
$100.00 |
$500,000 |
D/D |
(5,000) |
145,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-05-01 |
4 |
OE |
$19.09 |
$190,850 |
D/D |
10,000 |
155,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-05-01 |
4 |
AS |
$103.23 |
$1,248,871 |
D/D |
(12,000) |
143,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-05-15 |
4 |
AS |
$110.01 |
$2,750,210 |
D/D |
(25,000) |
143,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-05-15 |
4 |
OE |
$19.09 |
$479,947 |
D/D |
25,000 |
168,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-06-01 |
4 |
AS |
$113.14 |
$1,931,891 |
D/D |
(17,000) |
141,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-06-01 |
4 |
OE |
$23.60 |
$355,647 |
D/D |
15,000 |
158,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-07-01 |
4 |
OE |
$23.76 |
$356,325 |
D/D |
15,000 |
156,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-07-01 |
4 |
AS |
$115.91 |
$1,984,446 |
D/D |
(17,000) |
139,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-08-03 |
4 |
OE |
$23.76 |
$356,325 |
D/D |
15,000 |
154,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-08-03 |
4 |
AS |
$118.93 |
$2,024,870 |
D/D |
(17,000) |
137,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-09-01 |
4 |
AS |
$102.32 |
$1,233,008 |
D/D |
(12,000) |
135,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-09-01 |
4 |
OE |
$23.76 |
$242,208 |
D/D |
10,000 |
147,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-09-15 |
4 |
AS |
$110.00 |
$550,000 |
D/D |
(5,000) |
135,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-09-15 |
4 |
OE |
$24.30 |
$121,475 |
D/D |
5,000 |
140,422 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2015-10-01 |
4 |
OE |
$24.30 |
$121,475 |
D/D |
5,000 |
140,422 |
0 |
- |
|
360 Records found
|
|
Page 12 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
